National Marrow Donor Program Executive and Leadership Team

Amy Ronneberg, the Chief Executive Officer at National Marrow Donor Program, directs the overarching strategic vision for the organization. Overseeing the transition to the NMDP brand, the Chief Executive Officer ensures alignment across all departments to facilitate life-saving cellular therapy connections. This leadership role involves managing complex stakeholder relationships and driving operational excellence to meet ambitious future goals. By optimizing resource allocation, Amy Ronneberg directly impacts the ability of the organization to scale donor recruitment and patient support services. Ronneberg maintains a focus on long-term sustainability while fostering innovation within the medical non-profit sector. Through rigorous oversight of organizational performance, the Chief Executive Officer secures the necessary infrastructure to support global health initiatives. Ultimately, Ronneberg guides the mission to expand access to life-saving treatments for patients worldwide, ensuring the organization remains a leader in the field of marrow and blood stem cell transplantation.

Katherine Heyerdahl, the Chief Financial Officer at National Marrow Donor Program, manages the fiscal health and long-term financial planning for the organization. Overseeing budgetary discipline, the Chief Financial Officer ensures that capital resources support critical donor registry operations and patient advocacy programs. This leadership role involves analyzing complex financial data to drive efficiency across all departments. By implementing robust fiscal controls, Katherine Heyerdahl directly impacts the capacity of the organization to fund life-saving research and medical logistics. Heyerdahl maintains transparency in financial reporting while coordinating with the Board to ensure alignment with strategic objectives. Through careful management of assets, the Chief Financial Officer secures the financial stability required for large-scale medical operations. Ultimately, Heyerdahl supports the mission by providing the economic foundation necessary to sustain and grow the global donor network, ensuring that financial resources translate into tangible patient outcomes.

Chris Arevalos-Jimenez, the President & Co-Founder at National Marrow Donor Program, drives the foundational mission and strategic growth of the organization. Overseeing key partnerships, the President & Co-Founder ensures that the organization maintains strong ties with medical institutions and community stakeholders. This leadership role involves fostering a culture of innovation to address the evolving needs of patients and donors. By championing the organizational mission, Chris Arevalos-Jimenez directly impacts the reach and effectiveness of donor recruitment efforts. Arevalos-Jimenez maintains a focus on long-term impact while guiding the organization through periods of significant brand evolution. Through the cultivation of strategic alliances, the President & Co-Founder supports the expansion of the registry into new markets. Ultimately, Arevalos-Jimenez secures the future of the organization by aligning operational activities with the core goal of providing life-saving cellular therapy to patients in need across diverse geographic regions.

Sydney Salamy, the Chapter President at National Marrow Donor Program, directs regional engagement and local donor recruitment initiatives. Overseeing community outreach programs, the Chapter President ensures that the organization maintains a strong presence in key markets to drive registry growth. This leadership role involves mobilizing volunteers and coordinating local events to increase awareness of cellular therapy. By fostering grassroots support, Sydney Salamy directly impacts the diversity and size of the donor pool. Salamy maintains alignment with national strategic goals while tailoring engagement tactics to specific regional demographics. Through the management of local partnerships, the Chapter President supports the broader mission of connecting patients with life-saving donors. Ultimately, Salamy drives the organization's impact by building a robust network of supporters at the community level, ensuring that the registry remains accessible and responsive to the needs of patients in various regions.

Komal Khoja, the President at National Marrow Donor Program, manages internal operations and organizational efficiency to support the mission of life-saving transplantation. Overseeing cross-functional teams, the President ensures that administrative processes align with the strategic objectives of the organization. This leadership role involves streamlining workflows to enhance the speed and accuracy of donor matching services. By optimizing internal systems, Komal Khoja directly impacts the operational capacity of the organization to handle increasing demand. Khoja maintains a focus on process improvement while coordinating with other executives to ensure seamless service delivery. Through the implementation of performance metrics, the President supports the achievement of key organizational milestones. Ultimately, Khoja drives the mission by ensuring that the internal machinery of the organization functions at peak performance, allowing for the efficient delivery of cellular therapy solutions to patients in need across the global network.

Erika Brandt, the President at National Marrow Donor Program, leads the development and execution of specialized programs designed to improve patient access to cellular therapy. Overseeing program management, the President ensures that initiatives are effectively implemented to meet the needs of diverse patient populations. This leadership role involves evaluating program performance and adjusting strategies to maximize impact. By directing program resources, Erika Brandt directly impacts the success of patient-centered services and donor support initiatives. Brandt maintains a focus on innovation while collaborating with clinical and operational teams to refine service delivery models. Through the oversight of project lifecycles, the President supports the organization's ability to adapt to changing medical and social environments. Ultimately, Brandt drives the mission by ensuring that specialized programs are executed with precision, directly contributing to the organization's goal of providing life-saving treatments to patients worldwide.

Rob Hanson, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer at National Marrow Donor Program, architects the digital infrastructure required for secure donor matching. Overseeing cybersecurity protocols, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer ensures the protection of sensitive medical data across all platforms. This leadership role involves integrating advanced technology solutions to streamline the registry process and enhance patient-donor connectivity. By fortifying network defenses, Rob Hanson directly impacts the reliability and security of the organization's digital assets. Hanson maintains rigorous compliance standards while driving innovation in data management systems. Through the implementation of scalable cloud solutions, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer supports the operational scale needed for global medical operations. Ultimately, Hanson secures the technological backbone that enables life-saving matches to occur with speed and precision.

Dennis Confer, the Chief Medical Officer at National Marrow Donor Program, establishes the clinical standards and medical protocols governing donor selection and transplantation. Overseeing medical research initiatives, the Chief Medical Officer ensures that all procedures adhere to the highest safety and efficacy benchmarks. This leadership role involves collaborating with clinical partners to advance the science of cellular therapy. By directing medical policy, Dennis Confer directly impacts the quality of care provided to patients awaiting life-saving transplants. Confer maintains oversight of clinical outcomes while guiding the organization through complex medical regulatory landscapes. Through the integration of evidence-based practices, the Chief Medical Officer supports the expansion of donor registry capabilities. Ultimately, Confer drives the medical mission by ensuring that every transplant process is optimized for patient success, leveraging deep clinical expertise to improve survival rates and enhance the overall effectiveness of the global donor network.